In the largest genome study to date, a team led by scientists at the University of Queensland (UQ) has analyzed genetic data of nearly 5.4 million people from 281 genome-wide association studies (GWAS ...

Milestone Pharmaceuticals’ rescue mission has delivered a pivotal primary endpoint hit. Thirty months after failing its first phase 3, the nasal spray treatment for abnormal heart rhythm has beaten ...

Research describes a computational model that captures the intricate muscular architecture of an octopus arm. Mechanical engineering PhD candidate Arman Tekinalp, fellow graduate student Seung Hyun ...

Although a manageable disease, diabetes imposes significant hurdles on patients, both in terms of personal care and financial costs. Fundamentally, the required frequency of blood glucose monitoring ...

Researchers have shown a single genetic test can be used alongside routine clinical data to find better cancer treatments. In a landmark study of more than 13,000 patients in England, scientists ...

Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate (p 0.0001) ...

MOUNTAIN VIEW, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the ...

New research by scientists in Switzerland shows supplementation with Urolithin A had exercise-like effects on muscle strength after 4-months (+12%), published in Cell Reports Medicine This is the ...

The pursuit of an active lifestyle does not end with age. Traditionally, physical activity is measured using devices called accelerometers. We all know someone who uses or has used a Fitbit to keep ...

Infants and children 5 years old and younger experienced only 'modest' delays in developmental milestones due to the COVID-19 pandemic disruptions and restrictions, a study finds. Infants and children ...

LAUSANNE, Switzerland & SAN FRANCISCO--(BUSINESS WIRE)--Amazentis, a spin-off of the Swiss Federal Institute of Technology (EPFL) pioneering scientific breakthroughs in cellular health and nutrition, ...